Patents by Inventor Travis T. Wager

Travis T. Wager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7300943
    Abstract: The invention provides compounds of formula (I) the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R1, R2, and R3 are as defined herein; pharmaceutical compositions thereof; and use thereof in the treatment of, inter alia, conditions, diseases, and symptoms such as diabetes, dementia, Alzheimer's Disease, stroke, schizophrenia, depression, hair loss, and cancer.
    Type: Grant
    Filed: June 23, 2004
    Date of Patent: November 27, 2007
    Assignee: Pfizer Inc.
    Inventor: Travis T. Wager
  • Patent number: 7241798
    Abstract: The invention is to compounds exhibiting neurokinin inhibitory properties, pharmaceutical compositions comprising same and methods of treatment for neurokinin-mediated conditions.
    Type: Grant
    Filed: June 7, 2005
    Date of Patent: July 10, 2007
    Assignee: Pfizer Inc.
    Inventors: Barbara E. Segelstein, Travis T. Wager, Willard M. Welch
  • Patent number: 7115600
    Abstract: This invention is directed to a compound of the formula I as defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition containing a compound of formula I, a method of treatment of a disorder or condition that may be treated by modulating histamine H3 receptors, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above, and a method of treatment of a disorder or condition selected from the group consisting of depression, mood disorders, schizophrenia, anxiety disorders, Alzheimer's disease, attention-deficit hyperactivity disorder (ADHD), psychotic disorders, sleep disorders, obesity, dizziness, epilepsy, motion sickness, respiratory diseases, allergy, allergy-induced airway responses, allergic rhinitis, nasal congestion, allergic congestion, congestion, hypotension, cardiovascular disease, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastro-intestinal tract, the method comprising a
    Type: Grant
    Filed: January 28, 2005
    Date of Patent: October 3, 2006
    Assignee: Pfizer Inc.
    Inventors: Travis T. Wager, Ramalakshmi Y. Chandrasekaran
  • Publication number: 20040266815
    Abstract: The present invention provides compounds of formula (I) 1
    Type: Application
    Filed: June 23, 2004
    Publication date: December 30, 2004
    Applicant: Pfizer Inc
    Inventors: Daniel W. Kung, Travis T. Wager
  • Publication number: 20020103185
    Abstract: The invention provides compounds of formula 1 1
    Type: Application
    Filed: August 28, 2001
    Publication date: August 1, 2002
    Inventors: Mark A. Sanner, Chris J. Helal, Christopher B. Cooper, Travis T. Wager